First, EGFR and NeuGcGM3 ganglioside expression on tumor sections from Lewis Lung carcinoma (3LL-D122) and breast carcinoma (4T1) were characterized by immunohistochemistry assay: Table 2 and Fig. 3. Here, EGFR is linked to breast carcinoma.